Research / JBL / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-20-001434 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
33.19% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.07% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.28% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
15.36% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
44.53% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
7.38% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
2.04% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.14% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.40% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Nov 30, 2019 0/9 normalized Level 3 Feb 29, 2020 8/9 normalized Level 3 May 31, 2020 8/9 normalized Level 3 Aug 31, 2020 8/9 normalized Level 3 Nov 30, 2020 8/9 normalized Level 3 Feb 28, 2021 9/9 normalized Level 3 May 31, 2021 9/9 normalized Level 3 Aug 31, 2021 9/9 normalized Level 3 Nov 30, 2021 9/9 normalized Level 3 Feb 28, 2022 9/9 normalized Level 3 May 31, 2022 9/9 normalized Level 3 Aug 31, 2022 9/9 normalized Level 3 Nov 30, 2022 9/9 normalized Level 3 Feb 28, 2023 9/9 normalized Level 3 May 31, 2023 9/9 normalized Level 3 Aug 31, 2023 9/9 normalized Level 3 Nov 30, 2023 9/9 normalized Level 3 Feb 29, 2024 9/9 normalized Level 3 May 31, 2024 9/9 normalized Level 3 Aug 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 9.87%
Current 33.19%
Delta 23.31% Capex Intensity Decreased
Previous 3.98%
Current 3.07%
Delta -0.91% Cash Generation Decreased
Previous 4.72%
Current 0.28%
Delta -4.44% Growth Increased
Previous 14.42%
Current 15.36%
Delta 0.94% Inventory Pressure Increased
Previous 11.96%
Current 44.53%
Delta 32.57% Margin Decreased
Previous 7.57%
Current 7.38%
Delta -0.19% Profitability Decreased
Previous 2.77%
Current 2.04%
Delta -0.74% R And D Intensity Decreased
Previous 0.17%
Current 0.14%
Delta -0.03% Sbc Intensity Increased
Previous 0.24%
Current 0.40%
Delta 0.16% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.